Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr; Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA. Dubois B, et al. Among authors: bakardjian h. Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002. Alzheimers Dement. 2016. PMID: 27012484 Free PMC article. Review.
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B. Hampel H, et al. Among authors: bakardjian h. Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22. Biochem Pharmacol. 2014. PMID: 24275164 Review.
Mechanical stress related to brain atrophy in Alzheimer's disease.
Levy Nogueira M, Lafitte O, Steyaert JM, Bakardjian H, Dubois B, Hampel H, Schwartz L. Levy Nogueira M, et al. Among authors: bakardjian h. Alzheimers Dement. 2016 Jan;12(1):11-20. doi: 10.1016/j.jalz.2015.03.005. Epub 2015 Jun 15. Alzheimers Dement. 2016. PMID: 26086185
Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S; GuidAge study group. Di Stefano F, et al. Among authors: bakardjian h. J Alzheimers Dis. 2015;48(3):793-804. doi: 10.3233/JAD-150013. J Alzheimers Dis. 2015. PMID: 26402073 Clinical Trial.
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert MO, Blennow K, Zetterberg H, O'Bryant SE, Johnson L, Galluzzi S, Bokde AL, Broich K, Herholz K, Bakardjian H, Dubois B, Jessen F, Carrillo MC, Aisen PS, Hampel H. Lista S, et al. Among authors: bakardjian h. J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S171-91. doi: 10.3233/JAD-150202. J Alzheimers Dis. 2015. PMID: 26402088 Review.
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.
Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR Jr, Sperling R, Cummings J, Blennow K, O'Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, Broich K, Andrieu S, de Schotten MT, Mangin JF, Lammertsma AA, Johnson K, Teipel S, Drzezga A, Bokde A, Colliot O, Bakardjian H, Zetterberg H, Dubois B, Vellas B, Schneider LS, Hampel H. Cavedo E, et al. Among authors: bakardjian h. J Prev Alzheimers Dis. 2014 Dec;1(3):181-202. doi: 10.14283/jpad.2014.32. J Prev Alzheimers Dis. 2014. PMID: 26478889 Free PMC article.
Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.
Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group. Teipel SJ, et al. Among authors: bakardjian h. Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005. Epub 2016 Feb 10. Neuropharmacology. 2016. PMID: 26876309 Clinical Trial.
No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints.
Teipel S, Bakardjian H, Gonzalez-Escamilla G, Cavedo E, Weschke S, Dyrba M, Grothe MJ, Potier MC, Habert MO, Dubois B, Hampel H; INSIGHT-preAD study group. Teipel S, et al. Among authors: bakardjian h. Neuroimage Clin. 2017 Oct 29;17:435-443. doi: 10.1016/j.nicl.2017.10.031. eCollection 2018. Neuroimage Clin. 2017. PMID: 29159056 Free PMC article.
Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds.
Habert MO, Bertin H, Labit M, Diallo M, Marie S, Martineau K, Kas A, Causse-Lemercier V, Bakardjian H, Epelbaum S, Chételat G, Houot M, Hampel H, Dubois B, Mangin JF; INSIGHT-AD study group. Habert MO, et al. Among authors: bakardjian h. Ann Nucl Med. 2018 Feb;32(2):75-86. doi: 10.1007/s12149-017-1221-0. Epub 2017 Dec 7. Ann Nucl Med. 2018. PMID: 29218458
47 results